Moderna Tests Lower-Dose Vaccines in Attempt to Boost Supply

Moderna may also need to expand work on boosters to cover for more variants, Chairman Noubar Afeyan said in interview with Bloomberg Television.

• Coronavirus may become endemic, much like seasonal flu
• Herd immunity can probably be judged only in hindsight: Afeyan
• Vaccinating children seems like the better approach considering Covid’s after-effects
• NOTE: Moderna to Supply Up to 500 Million Vaccine Doses to Covax

To contact the reporters on this story:
Francine Lacqua in London at flacqua@bloomberg.net;
Marthe Fourcade in Paris at mfourcade@bloomberg.net

To contact the editor responsible for this story:
Eric Pfanner at epfanner1@bloomberg.net

© 2021 Bloomberg L.P. All ...